BioSpace News Archive

Policy

ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022

ADC Therapeutics SA announced its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, has been filed with the U.S. Securities and Exchange Commission.

March 15, 2023
·
4 min read
Business

Champions Oncology Reports Quarterly Revenue of $12.8 Million

Champions Oncology, Inc., a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced its financial results for its third quarter of fiscal 2023, ended January 31, 2023.

March 15, 2023
·
12 min read
Business

Ventyx Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”) today announced that it will report financial results for the fourth quarter and full year 2022 after market close on March 23, 2023.

March 15, 2023
·
3 min read
Business

MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results

MaxCyte, Inc. announced its fourth quarter and full year ended December 31, 2022, financial results and provided initial 2023 revenue guidance.

March 15, 2023
·
17 min read
BioMidwest

GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine Industry Excellence Award at World Vaccine Congress

GeoVax Labs, Inc. congratulates its colleague and collaborator, Don Diamond, Ph.D. for recognition as a finalist for the Best Academic/Research Team Award, part of the Vaccine Industry Excellence Awards to be held during the World Vaccine Congress in Washington, DC on April 3-6, 2023.

March 15, 2023
·
2 min read
Biotech Bay

Adela to present data demonstrating detection of multiple cancer types at the American Association for Cancer Research Annual Meeting 2023

Adela, Inc. announced today that it will present data demonstrating the ability of its genome-wide methylome enrichment platform to detect multiple types of cancer at the American Association for Cancer Research (AACR) Annual Meeting from April 14-19, 2023.

March 15, 2023
·
2 min read
BriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”) has been selected to present four posters at the 2023 American Association for Cancer Research (AACR) Annual Meeting held from April 14 - 19, 2023 at Orange County Convention Center, Orlando, Florida.

March 15, 2023
·
4 min read
argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis

argenx (Euronext & Nasdaq: ARGX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for VYVGART® (efgartigimod alfa-fcab) as an add-on to standard therapy for the treatment of adult patients with gMG who are AChR antibody positive1.

March 15, 2023
·
6 min read
Business

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 29, 2023, at 4:30 p.m. Eastern Time to review 2022 fourth quarter and full year results.

March 15, 2023
·
1 min read
Deals

Miltenyi Biotec acquires biosensor company lino Biotech

lino Biotech announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023.

March 15, 2023
·
2 min read